The selective killing effect of adenoviral mediated HSV-tk/GCV suicide gene system controlled by hTERT promoter on bladder cancer cells

被引:0
|
作者
王亚轩
机构
[1] Shijiazhuang 050000
[2] 2nd Hos
[3] Dept Urol
[4] Hebei Med Univ
关键词
D O I
暂无
中图分类号
R737.14 [膀胱肿瘤];
学科分类号
100214 ;
摘要
To investigate the selective killing effect of adenoviral mediated herpes simplex virus-thymidine kinase/ganciclovir (HSV-tk/GCV) suicide gene system controlled by human telomerase reverse transcriptase (hTERT) promoter on bladder cancer cells in vitro.Methods Bladder cancer cell line 253J and human fibroblast cell line MRC-5 were transfected by the recombinant adenovirus of different multiplicities of infection (MOI),and the infection rate was measured by observing the expression of enhanced green fluorescent protein (EGFP) under the fluorescent microscopy.Ad-hTERT-HSV/tk and Ad-CMV-SHV/tk were transduced into 253J and MRC-5,followed by GCV treatment.The relative survival rate of cells in presence of prodrug GCV was measured with MTT method.Results Recombinant adenovirus Ad-hTERT-EGFP could selectively infect 253J cells,with the infection rate associated with the increasing MOI of recombinant adenovirus (P<0.01).When MOI was 1,the infection rate was 8.3%;when MOI was 1000,the infection rate was 100.0%.GCV significantly inhibited the growth of both cell lines (253J and MRC-5) infected with Ad-CMV-HSV/tk and the growth of only 253J infected with Ad-hTERT-HSV/tk (P<0.001).The survival rate of 253J was correlated with the concentration of both the prodrugs and MOI of recombinant adenovirus (P<0.01).When MOI was 1,with 1 μmol/L GCV,the survival rate of 253J was 95.4%;when MOI was 100,with 1000 μmol/L GCV,the survival rate of 253J was 6.1%.Conclusion Recombinant adenovirus vector containing EGFP can report the transfection rate accurately and easily.Adenoviral vector containing hTERT promoter for the HSV/tk plus GCV treatment appears to be highly selective in killing bladder cancer cell line in vitro.7 refs.2 tabs.
引用
收藏
页码:201 / 202
页数:2
相关论文
共 50 条
  • [31] Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes
    Faneca, H.
    Faustino, A.
    De Lima, M. C. Pedroso
    JOURNAL OF CONTROLLED RELEASE, 2008, 126 (02) : 175 - 184
  • [32] Interleukin-2 enhanced the anti-tumor effect of adenoviral-mediated HSV-tk gene therapy in murine bladder cancer model.
    Terao, S
    Shirakawa, T
    Goda, K
    Kamidono, S
    Gotoh, A
    JOURNAL OF UROLOGY, 2005, 173 (04): : 214 - 214
  • [33] Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo
    Kuriyama, S
    Kikukawa, M
    Masui, K
    Okuda, H
    Nakatani, T
    Akahane, T
    Mitoro, A
    Tominaga, K
    Tsujinoue, H
    Yoshiji, H
    Okamoto, S
    Fukui, H
    Ikenaka, K
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (03) : 374 - 380
  • [34] Cyclooxygenase-2 promoter can mitigate the lethal toxicity in HSV-TK based adenoviral suicide gene therapy of gastrointestinal cancers
    Yamamoto, M
    Alemany, R
    Adachi, Y
    Grizzle, WE
    Curiel, DT
    GASTROENTEROLOGY, 2001, 120 (05) : A10 - A10
  • [35] Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model
    Fogar, P
    Greco, E
    Basso, D
    Habeler, W
    Navaglia, F
    Zambon, CF
    Tormen, D
    Gallo, N
    Cecchetto, A
    Plebani, M
    Pedrazzoli, S
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (09): : 721 - 730
  • [36] Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system
    Zhang, Qicheng
    Liu, Zheng
    Hou, Jue
    Wang, Shuhui
    Liu, Chang
    Wei, Min
    Liu, Ying
    Shao, Yiming
    VACCINE, 2016, 34 (30) : 3447 - 3453
  • [37] Efficient transduction and suicide killing of primary ATL cells by a recombinant HIV vector carrying the HSV-TK gene.
    Miyake, K
    Suzuki, N
    Inokuchi, K
    Dan, K
    Shimada, T
    BLOOD, 1998, 92 (10) : 385B - 385B
  • [38] In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo
    Okada, T
    Caplen, NJ
    Ramsey, WJ
    Onodera, M
    Shimazaki, K
    Nomot, T
    Ajalli, R
    Wildner, O
    Morris, J
    Kume, A
    Hamada, H
    Blaese, RM
    Ozawa, K
    JOURNAL OF GENE MEDICINE, 2004, 6 (03): : 288 - 299
  • [39] Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells
    Suzuki, T
    Tadakuma, T
    Kunitomi, M
    Takayama, E
    Sato, M
    Asano, T
    Nakamura, H
    Hayakawa, M
    UROLOGIA INTERNATIONALIS, 2001, 67 (03) : 216 - 223
  • [40] Anti-cancer gene therapy using genetically modified MSCs expressing HSV-TK with controlled gene expression by pro-drug GCV
    Song, Chao
    Wang, Zhen
    Xiang, Juanjuan
    Tang, Jingqun
    Hirst, David
    Li, Gang
    BONE, 2008, 43 : S41 - S41